FB Pixel no script
MENU
KrASIA

China

Insights

Vivo Capital adopts asset-first biotech strategy to cut R&D inefficiency

Managing partner Shan Fu says the firm can generate stronger returns through its asset-centric accelerator model.

8 mins read
  • Mainland carmakers are using the city as a platform for global expansion.

    News

    Chinese automotives make inroads in Toyota-dominated Hong Kong taxi market

    2 mins read

Most Recent

See All